<ARTICLE>                                                  5
<CIK>                           0000722830
<NAME>                          IMMUNOMEDICS, INC.
<MULTIPLIER>                                               1
       
                                         
<PERIOD-TYPE>                               9-MOS
<FISCAL-YEAR-END>                           JUN-30-1999
<PERIOD-START>                              JUL-01-1998
<PERIOD-END>                                MAR-31-1998
<CASH>                                             4,448,408
<SECURITIES>                                       6,904,604
<RECEIVABLES>                                      1,483,734
<ALLOWANCES>                                         (33,458)
<INVENTORY>                                          888,086
<CURRENT-ASSETS>                                  14,312,828
<PP&E>                                            11,578,125
<DEPRECIATION>                                    (6,580,300)
<TOTAL-ASSETS>                                    19,535,653
<CURRENT-LIABILITIES>                              4,109,585
<BONDS>                                                    0
<PREFERRED-MANDATORY>                                      0
<PREFERRED>                                               13
<COMMON>                                             378,881
<OTHER-SE>                                        14,599,477
<TOTAL-LIABILITY-AND-EQUITY>                      19,535,653
<SALES>                                            4,833,156
<TOTAL-REVENUES>                                   5,761,563
<CGS>                                                184,528
<TOTAL-COSTS>                                     14,485,202
<OTHER-EXPENSES>                                           0
<LOSS-PROVISION>                                           0
<INTEREST-EXPENSE>                                         0
<INCOME-PRETAX>                                   (8,723,639)
<INCOME-TAX>                                               0
<INCOME-CONTINUING>                               (8,723,639)
<DISCONTINUED>                                             0
<EXTRAORDINARY>                                            0
<CHANGES>                                                  0
<NET-INCOME>                                      (8,723,639)
<EPS-PRIMARY>                                          (0.24)
<EPS-DILUTED>                                          (0.24)